Trending Now
Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) Reports Net Product Revenue of $29.2 Million...
Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) has announced its Q3 2020 financial results in which Firdapse® net revenue was $29.2 million and also provided...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Nabriva Therapeutics (NASDAQ:NBRV) Soars a Deal with Merck & Co., Inc....
The treatment of acute bacterial infections, which affect the skin and its structure should not be complicated. However, they turn out to be severe...
MAKE IT MODERN
LATEST REVIEWS
IPO’s to focus on today (AKRO, BCEL, PRVL, PSNL, GO, CMBM)
The futures are green this morning and after 7 straight days of new highs on the SPY and positive news out of...
MAKE IT MODERN
PERFORMANCE TRAINING
Protara Therapeutics Inc. (NASDAQ: TARA) Receives FDA Approval for IND for TARA-002 In NMIBC...
Protara Therapeutics Inc. (NASDAQ: TARA) has announced that the US FDA has approved its Investigational New Drug application for its experimental cell-based therapy, TARA-002,...
Pasithea Therapeutics Corp (NASDAQ: KTTA) Opens Second Clinic in London For IV Ketamine Therapy...
Pasithea Therapeutics Corp (NASDAQ: KTTA) has announced that its subsidiary, Pasithea Clinics, has opened a second clinical in Marylebone that offers intravenous ketamine therapy...
Top CBD, Cannabis, and Metaverse Momentum Stories Surface in August Rally (CRON, UBQU, TLRY,...
The rally across the stock market over the past six weeks has been sharp and powerful, driving new money off the sidelines and dealing...
Pitney Bowes Inc. (NYSE: PBI) Reports a 7% Revenue Growth in The Second Quarter...
Pitney Bowes Inc. (NYSE: PBI), an eCommerce company, recently released its financial and operational results for the second quarter of 2021. The company reported...
Heat Biologics Inc. (NASDAQ:HTBX) Receives Investigational New Drug Application Approval From The FDA For...
Heat Biologics Inc. (NASDAQ:HTBX) has announced that it has received FDA clearance for the Investigational New Drug application for PTX-35, which is developed by...
MAKE IT MODERN
